Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Bentall, Richard P.
and
Day, Jennifer C.
1994.
Psychological factors and neuroleptic therapy: Some neglected issues.
International Review of Psychiatry,
Vol. 6,
Issue. 2-3,
p.
217.
King, D.J.
1994.
The safety of newer and older antipsychotics.
European Neuropsychopharmacology,
Vol. 4,
Issue. 3,
p.
220.
Cohen, Lawrence J.
1994.
Risperidone.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 14,
Issue. 3,
p.
253.
Goldstein, Jeffrey M.
and
Arvanitis, Lisa A.
1995.
ICI 204,636 (SEROQUEL™): A Dibenzothiazepine Atypical Antipsychotic. Review of Preclinical Pharmacology and Highlights of Phase II Clinical Trials.
CNS Drug Reviews,
Vol. 1,
Issue. 1,
p.
50.
Oken, R.J.
1995.
Antihistamines, a possible risk factor for alzheimer's disease.
Medical Hypotheses,
Vol. 44,
Issue. 1,
p.
47.
Eiden, Fritz
and
Lentzen, Hans
1996.
Im Blickpunkt: Medizinische Chemie. Wirkstoffentwicklung in den letzten Jahren Antipsychotica, Teil 1.
Pharmazie in unserer Zeit,
Vol. 25,
Issue. 1,
p.
28.
Small, Joyce G.
Milstein, Victor
Malloy, Frederick W.
and
Miller, Marvin J.
1996.
Quantitative electroencephalographic frequencies and relative neuroleptic receptor affinities in schizophrenia.
Biological Psychiatry,
Vol. 39,
Issue. 11,
p.
986.
Tanaka, O.
Kondo, T.
Kaneko, S.
Mihara, K.
Otani, K.
and
Tokinaga, N.
1996.
A Method for Rapid Determination of Zotepine by Gas Chromatography-Mass Spectrometry.
Therapeutic Drug Monitoring,
Vol. 18,
Issue. 3,
p.
294.
Bartoszyk, G. D.
Bender, H. M.
Hellmann, J.
Schnorr, C.
and
Seyfried, C. A.
1996.
EMD 57445: A Selective Sigma Receptor Ligand with the Profile of an Atypical Neuroleptic.
CNS Drug Reviews,
Vol. 2,
Issue. 2,
p.
175.
Lieberman, Jeffrey A.
and
Fleischhacker, W. Wolfgang
1996.
Introduction.
British Journal of Psychiatry,
Vol. 168,
Issue. S29,
p.
7.
Bart Vrtunski, P.
Eric Konicki, P.
Young Kwon, K.
Jaskiw, George J.
and
Jaskiw, George E.
1996.
Effect of clozapine on motor function in schizophrenic patients.
Schizophrenia Research,
Vol. 20,
Issue. 1-2,
p.
187.
Wang, Zhongrui
and
Rebec, George V.
1996.
Amygdaloid neurons respond to clozapine rather than haloperidol in behaving rats pretreated with intra-amygdaloid amphetamine.
Brain Research,
Vol. 711,
Issue. 1-2,
p.
64.
Meise, Ullrich
and
Fleischhacker, W. Wolfgang
1996.
Perspectives on Treatment Needs in Schizophrenia.
British Journal of Psychiatry,
Vol. 168,
Issue. S29,
p.
9.
Tanríverdi, Nilgün
and
Yazící, Kâzím M.
1996.
Immediate recurrence of psychotic symptoms after discontinuation of clozapine: A case report.
Biological Psychiatry,
Vol. 39,
Issue. 9,
p.
814.
Nyberg, Svante
Nakashima, Yoshifumi
Nordström, Anna-Lena
Halldin, Christer
and
Farde, Lars
1996.
Positron Emission Tomography of in-vivo Binding Characteristics of Atypical Antipsychotic Drugs.
British Journal of Psychiatry,
Vol. 168,
Issue. S29,
p.
40.
Hirsch, Steven R.
Link, Christopher G. G.
Goldstein, Jeffrey M.
and
Arvanitis, Lisa A.
1996.
ICI 204, 636: A New Atypical Antipsychotic Drug.
British Journal of Psychiatry,
Vol. 168,
Issue. S29,
p.
45.
Bonwick, Richard J.
Hopwood, Malcolm J.
and
Morris, Philip L.R
1996.
Neuroleptic Malignant Syndrome and Risperidone: A Case Report.
Australian & New Zealand Journal of Psychiatry,
Vol. 30,
Issue. 3,
p.
419.
Minchin, Susan A.
and
Csernansky, John G.
1996.
Antipsychotics.
Vol. 120,
Issue. ,
p.
1.
Love, Raymond C.
1996.
Novel versus Conventional Antipsychotic Drugs.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 16,
Issue. 1P2,
Gutiérrez, Blanca
Fañanás, Lourdes
Arranz, María J.
Vallès, Vicenç
Guillamat, Roser
van Os, Jim
and
Collier, David
1996.
Allelic association analysis of the 5-HT2C receptor gene in bipolar affective disorder.
Neuroscience Letters,
Vol. 212,
Issue. 1,
p.
65.
eLetters
No eLetters have been published for this article.